Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Maraviroc by GSK for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Likelihood of Approval
Maraviroc is under clinical development by GSK and currently in Phase III for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). According...